Catatonia
- PMID: 28613592
- Bookshelf ID: NBK430842
Catatonia
Excerpt
Catatonia, a neuropsychiatric syndrome characterized by abnormal movements, behaviors, and withdrawal, is a condition that is most often seen in mood disorders but can also be seen in psychotic, medical, neurologic, and other disorders. Most studies on the incidence of catatonia find it to be between 5% - 20% in the acute inpatient psychiatric setting. Most episodes of catatonia can be classified as excited, retarded, or malignant. Symptoms can wax, wane, or change during these episodes, and patients affected can have periods of withdrawal and periods of excitation. Studies have suggested a connected pathway between the cortex, basal ganglia, and thalamus underpins these different subtypes and results in catatonic symptoms. Recognition and treatment of catatonia can play an important part in both psychiatric and medical treatment as it can inhibit treatment, confusing diagnoses, and be potentially fatal if untreated.
There are a few different catatonia rating scales that have been developed to both screen for and monitor the progression of symptoms during an episode (e.g., Bush-Francis Catatonia Rating Scale and the Northoff Catatonia Scale), but the DSM-V gives 12 categories for symptoms that can lead to a diagnosis of catatonia. These symptoms include stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerisms, stereotypy, agitation not influenced by external stimuli, grimacing, echolalia, and echopraxia. At least three of these symptoms must be present for the diagnosis of catatonia. Some other criteria used in the Bush-Francis rating scale include automatic obedience, autonomic abnormalities, and the presence of a grasp reflex. These together present a wide variety of symptoms that can be present, and while there is a crossover between them and aspects of other illnesses, findings such as waxy flexibility, posturing, and automatic obedience can be more specific for catatonia.
Copyright © 2024, StatPearls Publishing LLC.
Conflict of interest statement
Sections
Similar articles
-
Zolpidem in Elderly Patients With Acute Treatment Resistant Catatonia: A Case Report.Hosp Pharm. 2023 Oct;58(5):444-447. doi: 10.1177/00185787231161514. Epub 2023 Mar 22. Hosp Pharm. 2023. PMID: 37711409
-
[Catatonia: resurgence of a concept. A review of the international literature].Encephale. 2002 Nov-Dec;28(6 Pt 1):481-92. Encephale. 2002. PMID: 12506260 Review. French.
-
Phenomenology and treatment of Catatonia: A descriptive study from north India.Indian J Psychiatry. 2011 Jan;53(1):36-40. doi: 10.4103/0019-5545.75559. Indian J Psychiatry. 2011. PMID: 21431006 Free PMC article.
-
Schizophrenia with prominent catatonic features ('catatonic schizophrenia') III. Latent class analysis of the catatonic syndrome.Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):81-5. doi: 10.1016/j.pnpbp.2008.10.010. Epub 2008 Oct 28. Prog Neuropsychopharmacol Biol Psychiatry. 2009. PMID: 18992297
-
Catatonia associated with pediatric postoperative cerebellar mutism syndrome.Childs Nerv Syst. 2024 Jul;40(7):2019-2032. doi: 10.1007/s00381-024-06392-x. Epub 2024 Apr 17. Childs Nerv Syst. 2024. PMID: 38630268 Review.
References
-
- Tormoehlen LM, Rusyniak DE. Neuroleptic malignant syndrome and serotonin syndrome. Handb Clin Neurol. 2018;157:663-675. - PubMed
-
- Westfall NC, Mavrides NA, Coffey BJ. Multidisciplinary Management of Adolescent Early-Onset, Treatment-Resistant Schizophrenia Complicated by Avoidant/Restrictive Food Intake Disorder and Catatonia in Acute Exacerbations. J Child Adolesc Psychopharmacol. 2018 Nov;28(9):663-666. - PubMed
-
- Leroy A, Corfiotti C, Nguyen The Tich S, Ferrafiat V, Amad A, Jardri R, Medjkane F. Catatonia Associated With a SCN2A-Related Disorder in a 4-Year-Old Child. Pediatrics. 2018 Nov;142(5) - PubMed
Publication types
LinkOut - more resources
Full Text Sources